SEARCH

SEARCH BY CITATION

References

  • 1
    Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000;12:121127.
  • 2
    Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000;18:217242.
  • 3
    Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998;187:875883.
  • 4
    Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998;101:746754.
  • 5
    Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998;187:129134.
  • 6
    D'Ambrosio D, Iellem A, Bonecchi R, Mazzeo D, Sozzani S, Mantovani A et al. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol 1998;161:51115115.
  • 7
    Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997;277:20052007.
  • 8
    Panina-Bordignon P, Papi A, Mariani M, Di Lucia P, Casoni G, Bellettato C et al. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest 2001;107:13571364.
  • 9
    Durham SR. Allergic inflammation. Pediatr Allergy Immunol 1993;4:712.
  • 10
    Robinson D, Hamid Q, Bentley A, Ying S, Kay AB, Durham SR. Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993;92:313324.
  • 11
    Lamkhioued B, Renzi PM, Bi-Younes S, Garcia-Zepada EA, Allakhverdi Z, Ghaffar O et al. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol 1997;159:45934601.
  • 12
    Ponath PD, Qin S, Post TW, Wang J, Wu L, Gerard NP et al. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med 1996;183:24372448.
  • 13
    Uguccioni M, Mackay CR, Ochensberger B, Loetscher P, Rhis S, LaRosa GJ et al. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest 1997;100:11371143.
  • 14
    Humbles AA, Lu B, Friend DS, Okinaga S, Lora J, Al-Garawi A et al. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc Natl Acad Sci U S A 2002;99:14791484.
  • 15
    Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998;102:558562.
  • 16
    Durham SR, Till SJ. Immunologic changes associated with allergen immunotherapy. J Allergy Clin Immunol 1998;102:157164.
  • 17
    Wachholz PA, Nouri-Aria KT, Wilson DR, Walker SM, Verhoef A, Till SJ et al. Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1:Th2 cytokine ratios. Immunology 2002;105:5662.
  • 18
    Till SJ, Jopling LA, Wachholz PA, Robson RL, Qin S, Andrew DP et al. T cell phenotypes of the normal nasal mucosa: induction of Th2 cytokines and CCR3 expression by IL-4. J Immunol 2001;166:23032310.
  • 19
    Van Hooijdonk CA, Glade CP, Van Erp PE. TO-PRO-3 iodide: a novel HeNe laser-excitable DNA stain as an alternative for propidium iodide in multiparameter flow cytometry. Cytometry 1994;17:185189.
  • 20
    Francis JN, Jacobson MR, Lloyd CM, Sabroe I, Durham SR, Till SJ. CXCR1+CD4+ T cells in human allergic disease. J Immunol 2004;172:268273.
  • 21
    Lloyd CM, Delaney T, Nguyen T, Tian J, Martinez A, Coyle AJ et al. CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. J Exp Med 2000;191:265274.
  • 22
    Yawalkar N, Uguccioni M, Scharer J, Braunwalder J, Karlen S, Dewald B et al. Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol 1999;113:4348.
  • 23
    Gerber BO, Zanni MP, Uguccioni M, Loetscher M, Mackay CR, Pichler WJ et al. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Curr Biol 1997;7:836843.
  • 24
    Wang CR, Chen PC, Liu MF. Increased circulating CCR3+ type 2 helper T cells in house dust mite-sensitive Chinese patients with allergic diseases. Asian Pac J Allergy Immunol 2003;21:205210.
  • 25
    Campbell JD, Stinson MJ, Simons FE, HayGlass KT. Systemic chemokine and chemokine receptor responses are divergent in allergic versus non-allergic humans. Int Immunol 2002;14:12551262.
  • 26
    Campbell JJ, Brightling CE, Symon FA, Qin S, Murphy KE, Hodge M et al. Expression of chemokine receptors by lung T cells from normal and asthmatic subjects. J Immunol 2001;166:28422848.
  • 27
    Morgan AJ, Symon FA, Berry MA, Pavord ID, Corrigan CJ, Wardlaw AJ. IL-4-expressing bronchoalveolar T cells from asthmatic and healthy subjects preferentially express CCR 3 and CCR 4. J Allergy Clin Immunol 2005;116:594600.
  • 28
    Elsner J, Escher SE, Forssmann U. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases. Allergy 2004;59:12431258.